Development of a validated Chinese version of the inflammatory bowel disease disability index.
Inflammatory bowel disease disability index (IBD-DI) has been used to evaluate functional status for inflammatory bowel disease (IBD) patients. The study was to develop a reliable Chinese version of IBD-DI (C-IBD-DI). Consecutive IBD patients and controls were recruited from June 2016 to July 2017 in the First Affiliated Hospital of Zhejiang University in China to complete IBD-DI, Inflammatory Bowel Disease Questionnaire-32 (IBDQ-32), Hamilton Anxiety Rating Scale (HAMA) and Hamilton Depression Rating Scale-24 items (HAMD-24). Validation process included item reduction, reliability and validity tests. 122 IBD patients completed the validation process. Factor analysis reduced the C-IBD-DI to 13 items. The Cronbach's α coefficient was 0.91. C-IBD-DI scores were highly correlated with IBDQ-32 (r = -0.79, p < 0.001), HAMA (r = 0.78, p < 0.001) and HAMD-24 (r = 0.81, p < 0.001). The total score of C-IBD-DI was significantly higher in patients with active IBD and those in remission. The intra-class correlation coefficient was 0.83 in stable IBD patients, representing a good test-retest reliability. Those with improved disease activity had a significantly lower C-IBD-DI score in the follow-up visit compared to baseline. IBD patients represented with worse disability levels and life quality than controls, and were more likely to be anxious and depressed, especially in those with active IBD. The validated C-IBD-DI comprises 13 questions and has highly acceptable reliability and validity. This article is protected by copyright. All rights reserved.